Starting on 3 drugs at time of diagnosis benefits Type 2 diabetics

Therapy produced stable glucose and hemoglobin A1C readings, and weight loss

2013-06-25

(Press-News.org) SAN ANTONIO (June 24, 2013) — Patients with type 2 diabetes fare significantly better if they are started on three medications at the time of diagnosis than if they are prescribed a single drug and have other therapies added later, a San Antonio researcher said June 22 at the 73rd Scientific Sessions of the American Diabetes Association in Chicago. The findings, from a study funded by the association, could revise the way physicians manage the endocrine disease.

Comparison

UT Medicine San Antonio physician Ralph DeFronzo, M.D., chief of the Diabetes Division in the School of Medicine at The University of Texas Health Science Center at San Antonio, presented two-year results from 134 participants studied at University Health System's Texas Diabetes Institute. Half of the subjects received the triple-therapy regimen while the other half received the conventional regimen recommended by the ADA. The standard regimen begins with a single agent (metformin), adds another (sulfonylurea) when the first agent fails, and then adds insulin injections as needed to control blood glucose after the second agent fails.

Dr. DeFronzo reported that:

Mean hemoglobin A1c, a test that strongly predicts the risk of diabetic blood vessel complications such as blindness, kidney failure, heart attacks, stroke and neuropathy, was 6.0 percent after 24 months in the triple-therapy group, compared to 6.6 percent in the conventional therapy group. (The American Diabetes Association and the European Association for Study of Diabetes recommend a maximum hemoglobin A1c level of 6.5 percent.)

While 42 percent of conventional-therapy participants failed to reach the 6.5 percent goal, only 17 percent of the triple-therapy recipients failed to reach it.

In home blood glucose monitoring, triple-therapy patients showed consistent results within the normal range, whereas patients on conventional therapy registered up and down spikes, many of which were out of the normal range.

Patients on triple therapy lost 2-3 pounds on average after two years while patients on conventional therapy gained 9-10 pounds.

Fifteen percent of patients on triple therapy experienced one episode of hypoglycemia (low blood glucose), while 46 percent of those on conventional therapy had at least one hypoglycemic event.

Core deficits corrected

The triple therapy combines agents that correct two core defects in type 2 diabetes — the inability to respond to insulin normally (insulin resistance), and failure of insulin-secreting beta cells to produce enough insulin. Insulin is the hormone that lowers blood glucose levels. Before the study, Dr. DeFronzo and his colleagues, including co-investigator, Muhammad Abdul-Ghani, M.D., Ph.D., of UT Medicine, hypothesized that the triple therapy would produce a greater, more durable reduction in hemoglobin A1c, reduce the fluctuation in plasma glucose by decreasing both fasting and between-meal glucose levels, and prevent weight gain, which is a side effect of traditional therapy.

Two years of normalcy

Two years into the three-year study, it is clear that the triple therapy is accomplishing these therapeutic goals, and that beta cells are being preserved and the body is being sensitized to insulin. "These drugs are not cures, but patients are basically normal while taking them," Dr. DeFronzo said. "They are not going to develop the microvascular (blood vessel) complications as long as their blood glucose level remains within the normal range."

3 drugs, 3 mechanisms

The triple therapy consists of metformin, a drug that Dr. DeFronzo helped develop in the 1990s; pioglitazone, a newer class of medication for type 2 diabetes; and exenatide, another newer class of drug. Each drug works by a different mechanism, Dr. DeFronzo said. Conventional therapy is to start the patient on metformin and when the response stops, add a class of medication called a sulfonylurea. When those no longer work, the patient is placed on insulin.

Factors for patients, doctors to weigh

Problems with the conventional approach include weight gain, episodes of hypoglycemia and failure to prevent beta cell failure. The conventional approach is less expensive, however.

"We should tell people which drugs work better," Dr. DeFronzo said. "The individuals and doctors need to decide whether they can afford the treatment."

Failure at 10 years out

According to the United Kingdom Prospective Diabetes Study, patients on conventional therapy had an average hemoglobin A1c level of 8.6 percent after a mean of 10 years of follow-up, and nearly two-thirds (65 percent) were on insulin for glucose control.

The Texas Diabetes Institute, a program of University Health System, is the nation's largest and most comprehensive center, entirely devoted to diabetes prevention, treatment, education, professional training and the relentless search for a cure. Texas Diabetes Institute is located where it is most needed, on San Antonio's West Side, where the incidence of diabetes is the highest in the nation. INFORMATION:

For current news from the UT Health Science Center San Antonio, please visit our news release website, like us on Facebook or follow us on Twitter.

About UT Medicine San Antonio

UT Medicine San Antonio is the clinical practice of the School of Medicine at the UT Health Science Center San Antonio. With more than 700 doctors – all School of Medicine faculty – UT Medicine is the largest medical practice in Central and South Texas. Expertise is in more than 100 medical specialties and subspecialties. Primary care doctors and specialists see patients in private practice at UT Medicine's flagship clinical home, the Medical Arts & Research Center (MARC), located at 8300 Floyd Curl Drive, San Antonio 78229. Most major health plans are accepted, and UT Medicine physicians also practice at several local and regional hospitals. Call (210) 450-9000 to schedule an appointment, or visit http://www.UTMedicine.org for a list of clinics and phone numbers.

About University Health System

University Health System is a nationally recognized academic medical center and network of outpatient health centers, owned by the taxpayers of Bexar County. University Health System is consistently recognized as a leader for going paperless with electronic medical records and is the first public health system in Texas to be designated as Magnet Hospital by the American Nurses Credentialing Center. University Hospital, its 496-bed acute care hospital, is the primary teaching hospital for the University of Texas Health Science Center San Antonio, consistently named Best Regional Hospital U.S. News & World Report and is one of just 15 Level I trauma centers in Texas. University Health System's Community First Health Plans is the region's only locally-owned, nonprofit HMO and San Antonio AirLIFE, jointly owned by University Health System, is a national leader in emergency air medical transport. For more, please go online at UniversityHealthSystem.com.

END

ELSE PRESS RELEASES FROM THIS DATE:

New optical metrics can identify patients on 'fast track' to decreased vision

2013-06-25

Philadelphia, Pa. (June 24, 2013) - Sophisticated new optical quality metrics can identify older adults likely to have more rapid age-related declines in vision, suggests a study, "Factors Accounting for the 4-Year Change in Acuity in Patients Between 50 and 80 Years", in the July issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. The study by Darren E. Koenig, OD, PhD, and colleagues of University of Houston College of Optometry defines ...

Resilience in the wake of Superstorm Sandy

2013-06-25

Chicago, June 24, 2013—The Associated Press-NORC Center for Public Affairs Research has released results of a major survey exploring resilience of people and neighborhoods directly affected by Superstorm Sandy. The study reveals the importance of social factors such as neighborhood bonds and social supports in coping with the storm and its aftermath. Striking landfall in the United States on October 29, 2012, Superstorm Sandy affected large areas of coastal New York and New Jersey, devastated communities, killed more than 130 people, and caused tens of billions of ...

2 mutations triggered an evolutionary leap 500 million years ago

2013-06-25

Evolution, it seems, sometimes jumps instead of crawls. A research team led by a University of Chicago scientist has discovered two key mutations that sparked a hormonal revolution 500 million years ago. In a feat of "molecular time travel," the researchers resurrected and analyzed the functions of the ancestors of genes that play key roles in modern human reproduction, development, immunity and cancer. By re-creating the same DNA changes that occurred during those genes' ancient history, the team showed that two mutations set the stage for hormones like estrogen, ...

Resourceful microbes reign in world's oceans

2013-06-25

EAST BOOTHBAY, MAINE -- A research team led by Bigelow Laboratory for Ocean Sciences has discovered that marine microbes are adapted to very narrow and specialized niches in their environment. This may explain why so few of these microbes—usually less than 1%—can be grown for study in the laboratory. By utilizing new genetic tools, the researchers' new ability to read and interpret genetic information from the remaining 99% will be pivotal in detecting and mitigating the impact of human activities in the ocean. Funded by the National Science Foundation, the study was published ...

Changing minds about climate change policy can be done -- sometimes

2013-06-25

COLUMBUS, Ohio – Some open-minded people can be swayed to support government intervention on climate change – but only if they are presented with both the benefits and the costs, a new study suggests. Researchers found that those who were open-minded didn't change their view if they heard arguments for only one side of the issue. People who are relatively more closed-minded did not change their mind regardless of the messages they received, or what their original views were. There was also no evidence of open-minded people becoming less supportive of government intervention, ...

Bacterial DNA may integrate into human genome more readily in tumor tissue

2013-06-25

Bacterial DNA may integrate into the human genome more readily in tumors than in normal human tissue, scientists have found. The researchers, affiliated with the University of Maryland School of Medicine's Institute for Genome Sciences, analyzed genomic sequencing data available from the Human Genome Project, the 1,000 Genomes Project and The Cancer Genome Atlas. They considered the phenomenon of lateral gene transfer (LGT), the transmission of genetic material between organisms in a manner other than than traditional reproduction. Scientists have already shown ...

Rural women less likely to get radiation therapy after lumpectomy for breast cancer

2013-06-25

ROCHESTER, Minn. -- Rural women with breast cancer are less likely than their urban counterparts to receive recommended radiation therapy after having a lumpectomy, a breast-sparing surgery that removes only tumors and surrounding tissue, a study by Mayo Clinic and others found. The difference is one of several rural disparities in breast cancer diagnosis and treatment the researchers discovered. The findings are being presented at the AcademyHealth Annual Research Meeting in Baltimore. "These study results are concerning," says Elizabeth Habermann, Ph.D., associate scientific ...

Penn psychologists show that quality matters more than quantity for word learning

2013-06-25

Several studies have shown that how much parents say to their children when they are very young is a good predictor of children's vocabulary at the point when they begin school. In turn, a child's vocabulary size at school entry strongly predicts level of success throughout schooling even into high school and college. A new study by psychologists at the University of Pennsylvania now shows that early vocabulary improvement is likely to have more to do with the "quality" of the interactions in which the words are used rather than the sheer quantity of speech directed ...

One man's tall is another man's small

2013-06-25

Just what size is a "small" drink—8 ounces, 12 ounces, 16 ounces? The truth is, those are all "small" sizes depending on what restaurants and fast food joints you go to. As customers, we are used to ordering food based on relative size, but according to a new study from Cornell University, these seemingly standard labels impact our entire eating experience. Dr. David R. Just and Dr. Brian Wansink of the Cornell Food & Brand Lab designed a study to understand how portion labels impact what you're willing to pay for your food as well as how much you actually eat. The researchers ...

Addiction relapse might be thwarted by turning off brain trigger

2013-06-25

A new study by researchers at the Ernest Gallo Clinic and Research Center at UC San Francisco offers encouraging findings that researchers hope may one day lead to a treatment option for people who suffer from alcohol abuse disorders and other addictions. In the study, conducted in rats, the UCSF researchers were able to identify and deactivate a brain pathway linked to the memories that cause cravings for alcohol, thus preventing the animals from seeking alcohol and drinking it, the equivalent of relapse. "One of the main causes of relapse is craving, triggered by ...

LAST 30 PRESS RELEASES:

What can polymers teach us about curing Alzheimer's disease?

Lead-free alternative discovered for essential electronics component

BioCompNet: a deep learning workflow enabling automated body composition analysis toward precision management of cardiometabolic disorders

Nonlinear association between systemic immune-inflammation index and in-hospital mortality in critically ill patients with chronic obstructive pulmonary disease and atrial fibrillation: a cross-sectio